Clementia Pharmaceuticals - 48 Year Dividend Yield History | CMTA

Historical dividend payout and yield for Clementia Pharmaceuticals (CMTA) since 1971. The current TTM dividend payout for Clementia Pharmaceuticals (CMTA) as of March 22, 2019 is $0.00. The current dividend yield for Clementia Pharmaceuticals as of March 22, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.986B $0.000B
Clementia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. It develops disease-modifying treatments for patients suffering from debilitating bone and other diseases. The company's lead product consists of palovarotene, a novel RAR? agonist, to treat fibrodysplasia ossificans progressiva, multiple osteochondroma and other diseases. Clementia Pharmaceuticals Inc. is based in Montreal, Canada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.409B 13.32
Gilead Sciences (GILD) United States $82.806B 10.54
Bio-Techne Corp (TECH) United States $7.570B 51.00